IMMX Stock Price
IMMX
IMMX stock price is $8.06 (+11.94% on the day), giving IMMX a market cap of $596.90M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
IMMX Stock Overview
- Price
- $8.06
- Previous close
- $7.20
- Open
- $7.24
- Market cap
- $596.90M
- 1-year price target
- $24.29
- MarketXLS Rank
- 40
About IMMX
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and immune-dysregulated diseases in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and colorectal cancer; and NXC-201 for relapsed/refractory multiple myeloma. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMMX | $8.06 | +11.9% | 1.44M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |